Softwr
Form Bio logo

Form Bio

Computational platform for cell and gene therapy design and manufacturability

As of 31 August 2026, Form Bio's pricing is not published; the vendor quotes on request. A cell and gene therapy computational platform that has narrowed sharply from general life sciences data tooling to AAV construct design and manufacturability prediction. Softwr lists it under Research. Form Bio is available on Web, Cloud.

Overview

What Form Bio does

Form Bio builds computational software for genetic medicine development, focused on cell and gene therapy. Its current offering, FormManufacturing, launched in 2026 as an AAV-focused platform that predicts, optimises and monitors manufacturability from construct design through to commercial scale-up, combining AI-driven payload design optimisation with deep genomic characterisation of what actually gets produced. The problem it addresses is a real one in the field: the therapy that is designed and the therapy that is manufactured consistently are frequently not the same thing, and that gap is discovered expensively and late. The history is what a buyer needs. Form Bio spun out of Colossal Biosciences in 2022 as a broader computational life sciences platform with general bioinformatics and data collaboration tooling, and has since narrowed to cell and gene therapy, and within that to AAV. That is a rational focus for a company chasing a defensible market, but it means older product descriptions, comparison articles and reference customers may describe capabilities that are no longer the commercial priority. Anything you assume from a 2023 evaluation should be re-checked. Buyers are gene therapy developers, primarily biotechs with AAV programmes, and their CDMO partners. Pricing is not published and arrives through a sales process, which for a platform of this kind normally means an annual subscription plus programme-scoped analysis work. The trade-off is concentration risk on both sides: a narrow product from a young company, applied to a programme where the analysis results shape regulatory-facing decisions.

What people use it for

  • A gene therapy developer discovering manufacturability problems with an AAV construct late in process development and wanting to move that analysis earlier
  • A biotech comparing several candidate payload designs in silico before committing to expensive production runs
  • A CDMO characterising what a client construct actually produces against what was specified
  • A programme team needing genome integrity evidence to support regulatory conversations about product consistency

The honest half

Where it falls short

Concrete and checkable, so you can decide whether any of them matter to you. This is the half of a review a vendor will not write about Form Bio.

  • The company has pivoted twice since spinning out of Colossal Biosciences in 2022, from general computational life sciences to cell and gene therapy and then to AAV manufacturability, so any evaluation more than a year old describes a product that is no longer the commercial focus.
  • The current offering launched AAV-focused, so developers working in lentiviral, mRNA or cell therapy modalities are outside the scope the platform was built and validated for.
  • No pricing is published and engagements are scoped per programme, which makes it impossible to size the commitment before entering a sales process.
  • This is a young venture-funded company whose analyses feed regulatory-facing decisions, so continuity of the vendor over a multi-year development programme is a genuine diligence question rather than a formality.
  • Predictive manufacturability models need real production data to be trustworthy, and the value depends on how much of that a young vendor has accumulated, which is difficult for a buyer to verify independently.

Cross-shopped

What people choose instead of Form Bio

Each pairing was judged by two reviewers asking whether a buyer would genuinely weigh the two against each other. The ones that failed were deleted rather than published.

  • Form Bio logo
    Form Bio
    vs
    Benchling logo
    Benchling

    Benchling: If you need general molecular biology design and registry tooling rather than AAV manufacturability prediction

Pricing

What Form Bio costs

Taken from the vendor's own pricing page. Prices move, so check before you buy.

FormManufacturing

On request

  • Pricing only through a sales process
  • Scoped per therapeutic programme rather than per seat
  • AAV-focused offering at launch
  • Analysis and characterisation services quoted alongside platform access
  • No public price list or self-service tier

Capabilities

Features

  • FormManufacturing

    AAV-focused platform predicting and monitoring manufacturability from design to scale-up

  • Payload design optimisation

    AI-driven construct and payload optimisation ahead of production

  • Genome integrity analysis

    Deep genomic characterisation of what is actually produced versus what was designed

  • Manufacturability prediction

    Forecasting of production risks before committing to a manufacturing run

  • In silico workflows

    Computational analysis replacing some wet-lab iteration cycles

  • Scale-up monitoring

    Tracking of construct behaviour through to commercial scale production

  • Cell and gene therapy focus

    Tooling built for CGT rather than adapted from general bioinformatics

  • Collaboration

    Shared analysis between developer and manufacturing partner

Answered, with sources

Questions people ask

Each answer names the page it came from, so you can check it rather than take our word for it.

What does Form Bio sell now?

FormManufacturing, launched in 2026, an AAV-focused platform for predicting, optimising and monitoring manufacturability of genetic medicines from construct design through scale-up.

Is it still a general bioinformatics platform?

No. It has narrowed from broad computational life sciences tooling to cell and gene therapy, and within that to AAV.

Where did the company come from?

It spun out of Colossal Biosciences in 2022.

Is pricing published?

No. Engagements are scoped per programme through a sales process.

Share

Keep looking

Where to go from Form Bio

Best Research software for

Compare Form Bio with

Other Research software

  • R&D cloud for biotechnology research and molecular biology

    Free plan13 researched notes
  • Regulated cloud platform for genomic and multiomic data, with GxP and FedRAMP coverage

    Pricing on request10 researched notes
  • Research informatics group behind GraphPad Prism, SnapGene, Geneious and LabArchives, now owned by Siemens

    Pricing on request12 researched notes
  • Cloud bioinformatics platform and trusted research environment, sold by Velsera

    Pricing on request12 researched notes
  • Open biomedical research platform for genomic analysis, priced only by the cloud you consume

    Open source12 researched notes
  • Physics based molecular modelling and drug discovery software, licensed by token pool

    Pricing on request10 researched notes
  • Science-aware laboratory platform combining LIMS, ELN and scientific data management

    Pricing on request13 researched notes
  • Session replay and heatmaps

    Free plan11 researched notes
  • Cheminformatics toolkits and structure handling, now a Certara subsidiary

    Pricing on request12 researched notes
  • Electronic lab notebook, LIMS and inventory in one system, now sold under the Cenevo group

    Pricing on request12 researched notes
  • A powerful knowledge base on top of a local folder of plain text Markdown files

    Free plan10 researched notes
  • Reference management essentials

    From $4.15/mo12 researched notes
  • Edit video by editing its transcript, built for researchers rather than video editors

    From $12/mo12 researched notes
  • Live AI-moderated conversations with hundreds of participants at once, analysed in real time

    Pricing on request12 researched notes
  • No-code lab operating system combining LIMS, ELN and inventory for biotech teams

    Pricing on request12 researched notes
  • Cloud bioinformatics platform and trusted research environment, sold by Velsera

    Pricing on request12 researched notes
  • Physics based molecular modelling and drug discovery software, licensed by token pool

    Pricing on request10 researched notes

Softwr does not host reviews and shows no star rating for Form Bio, because a rating we did not collect is not ours to publish. What is here is the pricing and platform detail from the vendor’s own pages, limitations we could state concretely, and alternatives a reviewer confirmed people weigh against it. Tell us if any of it is wrong.

More on Form Bio

Best Research software alternatives

Science-aware laboratory platform combining LIMS, ELN and scientific data management

quote

R&D cloud for biotechnology research and molecular biology

Free for academics, quoted for organisations

UX research repository for tagging notes, building insights and finding them again years later

Flat monthly fee, unlimited users

Cheminformatics toolkits and structure handling, now a Certara subsidiary

quote

Laboratory information management from Abbott for regulated and public health labs

quote

Electronic data capture and eConsent for clinical trials, built for investigator-initiated studies as well as sponsors

quote

Enterprise LIMS with integrated ELN and biobanking capability

quote

Enterprise laboratory information management system for regulated labs

quote

Compare Form Bio with alternatives